Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20
  • There is currently no data for OSI

Significant contract extension

3 Aug 2022 07:00

RNS Number : 6865U
Osirium Technologies PLC
03 August 2022
Β 

3 August 2022

Β 

Osirium Technologies plc

("Osirium" or the "Group")

Β 

Significant contract extension

Β 

Continued commitment extends Osirium PAM usage for a further three years

Β 

Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity and IT automation software, is pleased to announce that it has agreed a three-year Privileged Access Management ("PAM") licence extension with an existing customer (the "Customer"), a leading global asset manager, with a total value of c. Β£0.5 million. This extension represents c. 30% of the total bookings achieved by the Group in 2021. The Customer, who has been using Osirium's PAM solution for six years, has committed to use PAM to protect 4,500 devices for another three years.

Β 

In line with the Group's SaaS business model, the full licence fee is payable at the outset and will be reflected in bookings and cash in the current financial year, with revenue being recognised over the three-year term, further underpinning management expectations for the current year.

Β 

In addition to the PAM renewal, the Customer also recently extended the use of the Group's Privileged Process Automation ("PPA") solution for a further 12 months. Since the customer first adopted the PPA solution in 2019, the user licence number has increased from 40 to over 75.

Β 

David Guyatt, Chief Executive Officer, commented: "We are delighted to have agreed this extension, which continues our partnership for another three years and reflects the value of our solutions in protecting mission-critical enterprise systems. Over the time of our engagement, the Customer has also adopted our PPA capability, demonstrating the potential of our 'land and expand' strategy and the trend toward combining automation and security solutions to deliver enhanced security functionality, in line with our product strategy."

Β 

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

David Guyatt, CEO

Rupert Hutton, CFO

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

William Ellis Hancock

Β 

About Osirium TechnologiesΒ Plc

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.

Β 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

Β 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
CNTPTMPTMTMMBJT
Date   Source Headline
3rd Apr 201811:58 amRNSHolding(s) in Company
3rd Apr 20187:00 amRNSHolding(s) in Company
27th Mar 20187:00 amRNSResults of General Meeting
26th Mar 20187:00 amRNSNotice of Final Results
6th Mar 20187:05 amRNSPlacing and Notice of General Meeting
28th Feb 20187:00 amRNSOsirium Announces Support for Microsoft Azure
21st Feb 20187:00 amRNSContract win
7th Feb 20187:00 amRNSOsirium Signs Progress Distribution
9th Jan 20187:00 amRNSTrading Update
23rd Nov 20177:00 amRNSContract win
9th Nov 20177:00 amRNSContract Win
1st Nov 20177:00 amRNSContract Win
25th Oct 20177:00 amRNSContract win
20th Oct 20177:00 amRNSTwo contract renewals with Think Money & M-Netics
12th Oct 20177:00 amRNSContract renewals
6th Oct 20172:28 pmRNSHolding(s) in Company
25th Sep 20177:00 amRNSInterim Results
21st Sep 201712:08 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSOsirium partners with EB2BCOM in Asia Pacific
16th Aug 20177:00 amRNSNotice of Interim Results
11th Aug 20177:00 amRNSChange of Nominated Adviser
14th Jul 20177:00 amRNSOsirium confirms DACH Distribution Partner
12th Jun 20177:00 amRNSOsirium extends European Presence
5th Jun 20177:00 amRNSOsirium named a 'Cool Vendor' by Gartner
1st Jun 20173:05 pmRNSResult of AGM
9th May 20177:00 amRNSAnnual Financial Report
3rd May 20177:00 amRNSFinal Results
21st Apr 20177:01 amRNSHolding(s) in Company
21st Apr 20177:00 amRNSHolding(s) in Company
20th Apr 201711:37 amRNSHolding(s) in Company
12th Apr 20177:00 amRNSNotice of Final Results
4th Apr 201711:52 amRNSHolding(s) in Company
16th Mar 20177:00 amRNSDistributor Appointed in Middle East & Nth Africa
2nd Mar 20177:00 amRNSOsirium Extends Global Footprint to Asia Pacific
6th Jan 20177:00 amRNSBusiness update
26th Sep 20162:31 pmRNSDirector/PDMR Shareholding
20th Sep 20167:00 amRNSDirectorate Change
13th Sep 20168:55 amRNSDirector/PDMR Shareholding
26th Aug 20167:00 amRNSContract Win
21st Jul 20167:00 amRNSInterim Results
10th May 20162:44 pmRNSHolding(s) in Company
27th Apr 20165:21 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSHolding(s) in Company
15th Apr 20167:00 amRNSAdmission to trading on AIM & First Day of Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.